Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Key performance metrics for wide market index funds in retirement include return consistency, volatility, and cost efficiency to monitor progress.
28,290 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
Singapore's companies dominate the Southeast Asia 500 by revenue, capturing roughly a third of the region's total. Th...
A contractor seeks over $1 million in damages from Kanye West over renovations at his Malibu beach house. The civil t...
Discover what the (sfl) 2026 earnings call implies for revenue trends, balance sheet health, and the road ahead. This...
A high-profile gambling creator walked away from a $30 million per year casino sponsorship, highlighting how creator-...
Costco posted a clean second-quarter beat, with revenue near $69.6B and EPS of $4.58, as memberships rise and digital...
Marvell Technology stock today is moving on a mix of data-center demand, strategic bets, and fresh analyst optimism. ...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
As memory names rally on AI hype, investors are flocking to a supplier of AI data-center silicon. Marvell Technology’...
A director at AMN Healthcare recently disclosed selling about 3,681 shares for roughly $114,000 as the stock jumped 4...